High-IAP HIPEC following cytoreduction enhances the cisplatinconcentration of the small bowel mesentery without affecting itspharmacokinetic advantage or increasing severe postoperative morbidities. Technical optimization of high-IAP HIPEC and prognostic implications should be addressed by future studies.